Patents by Inventor Anders Nedergaard

Anders Nedergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoassay for collagen type VI
    Patent number: 11634479
    Abstract: The present invention provides an immunological binding partner reactive with a C-terminal epitope of the C5 domain of the ?3 chain of collagen Type 6, and a method of immunoassay using the immunological binding partner for detecting and quantifying the C-terminal epitope. The invention also provides a method of investigating the rate of formation of extracellular matrix and a method for identifying a subject suitable for treatment with an insulin sensitizer.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: April 25, 2023
    Assignee: Nordic Bioscience A/S
    Inventors: Anders Nedergaard, Jannie Marie Sand, Shu Sun, Diana Julie Oersnes-Leeming, Kim Henriksen
  • Immunoassay for Collagen Type VI
    Publication number: 20190309055
    Abstract: The present invention provides an immunological binding partner reactive with a C-terminal epitope of the C5 domain of the ?3 chain of collagen Type 6, and a method of immunoassay using the immunological binding partner for detecting and quantifying the C-terminal epitope. The invention also provides a method of investigating the rate of formation of extracellular matrix and a method for identifying a subject suitable for treatment with an insulin sensitizer.
    Type: Application
    Filed: June 5, 2019
    Publication date: October 10, 2019
    Applicant: Nordic Bioscience A/S
    Inventors: Anders Nedergaard, Jannie Marie Sand, Shu Sun, Diana Julie Oersnes-Leeming, Kim Henriksen
  • Immunoassay for Collagen Type VI Sequence
    Publication number: 20180088129
    Abstract: The present invention provides an immunological binding partner reactive with a C-terminal epitope of the C5 domain of the ?3 chain of collagen Type 6, and a method of immunoassay using the immunological binding partner for detecting and quantifying the C-terminal epitope. The invention also provides a method of investigating the rate of formation of extracellular matrix and a method for identifying a subject suitable for treatment with an insulin sensitizer.
    Type: Application
    Filed: March 31, 2016
    Publication date: March 29, 2018
    Applicant: Nordic Bioscience A/S
    Inventors: Anders Nedergaard, Jannie Marie Sand, Shu Sun, Diana Julie Oersnes-Leeming, Kim Henriksen
  • Collagen Type VI Alpha-1 Assay
    Publication number: 20160077108
    Abstract: Provided is an antibody which binds to an epitope of collagen type VI alpha 1 comprised in the N-terminal globular domain internal amino acid sequence -ADWGQSRDAEEAISQ- (SEQ ID NO: 1). Also provided is a method of immunoassay for detecting in a biological sample an epitope comprised in the N-terminal globular domain internal amino acid sequence -ADWGQSRDAEEAISQ- (SEQ ID NO: 1) of collagen type VI alpha 1, by contacting the sample with the antibody, and determining the amount of binding of the antibody.
    Type: Application
    Filed: April 23, 2014
    Publication date: March 17, 2016
    Applicant: NORDIC BIOSCIENCE A/S
    Inventors: Diana Julie Leeming, Anders Nedergaard, Morten Karsdal